Literature DB >> 24873879

Effect of microRNA-145 on IL-1β-induced cartilage degradation in human chondrocytes.

Bo Yang1, Xia Kang2, Yan Xing1, Ce Dou3, Fei Kang3, Jianmei Li3, Yi Quan2, Shiwu Dong4.   

Abstract

MicroRNA-145 has been shown to regulate chondrocyte homeostasis. It seems that miR-145 is implicated in cartilage dysfunction in Osteoarthritis (OA). However, the functional role of miR-145 in interleukin-1 beta (IL-1β)-induced extracellular matrix (ECM) degradation of OA cartilage has never been clarified. Here, we show that miR-145 expression increased in OA chondrocytes and in response to IL-1β stimulation. We confirm that mothers against decapentaplegic homolog 3 (Smad3), a key factor in maintaining chondrocyte homeostasis, is directly regulated by miR-145. Modulation of miR-145 affects the expression of Smad3 causing a change of its downstream target gene expression as well as IL-1β-induced ECM degradation in OA chondrocytes. This indicates that miR-145 contributes to impaired ECM in OA cartilage probably in part via targeting Smad3.
Copyright © 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Extracellular matrix; Interleukin-1 beta; MicroRNA; MicroRNA-145; Osteoarthritis

Mesh:

Substances:

Year:  2014        PMID: 24873879     DOI: 10.1016/j.febslet.2014.05.033

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  39 in total

1.  Decreased expression of microRNA-130a correlates with TNF-α in the development of osteoarthritis.

Authors:  Zeng-Chun Li; Ning Han; Xin Li; Guang Li; Yang-Zhou Liu; Gui-Xin Sun; Yong Wang; Guo-Ting Chen; Guo-Feng Li
Journal:  Int J Clin Exp Pathol       Date:  2015-03-01

2.  MicroRNAs associated with osteoarthritis differently expressed in bone matrix gelatin (BMG) rat model.

Authors:  Zixin Min; Rui Zhang; Jianfeng Yao; Congshan Jiang; Yuanxu Guo; Fei Cong; Wei Wang; Jia Tian; Nannan Zhong; Jian Sun; Jie Ma; Shemin Lu
Journal:  Int J Clin Exp Med       Date:  2015-01-15

Review 3.  Deregulation and therapeutic potential of microRNAs in arthritic diseases.

Authors:  Rita Vicente; Danièle Noël; Yves-Marie Pers; Florence Apparailly; Christian Jorgensen
Journal:  Nat Rev Rheumatol       Date:  2015-12-24       Impact factor: 20.543

4.  Analysis of methylation datasets identified significantly changed genes and functional pathways in osteoarthritis.

Authors:  Bing Han; Zhong Zheng; Jingzhong Ren; Wenqiang Qiu; Xiangwei Li
Journal:  Clin Rheumatol       Date:  2019-08-02       Impact factor: 2.980

Review 5.  MicroRNAs in cartilage development, homeostasis, and disease.

Authors:  Fatemeh Mirzamohammadi; Garyfallia Papaioannou; Tatsuya Kobayashi
Journal:  Curr Osteoporos Rep       Date:  2014-12       Impact factor: 5.096

Review 6.  Human genome-wide expression analysis reorients the study of inflammatory mediators and biomechanics in osteoarthritis.

Authors:  J D Sandy; D D Chan; R L Trevino; M A Wimmer; A Plaas
Journal:  Osteoarthritis Cartilage       Date:  2015-11       Impact factor: 6.576

Review 7.  The complex landscape of microRNAs in articular cartilage: biology, pathology, and therapeutic targets.

Authors:  Helal Endisha; Jason Rockel; Igor Jurisica; Mohit Kapoor
Journal:  JCI Insight       Date:  2018-09-06

8.  MicroRNA-34a affects chondrocyte apoptosis and proliferation by targeting the SIRT1/p53 signaling pathway during the pathogenesis of osteoarthritis.

Authors:  Shiju Yan; Meng Wang; Jian Zhao; Hongtao Zhang; Chengpei Zhou; Lei Jin; Yinglong Zhang; Xiuchun Qiu; Baoan Ma; Qingyu Fan
Journal:  Int J Mol Med       Date:  2016-05-31       Impact factor: 4.101

9.  Overexpression of microRNA-634 suppresses survival and matrix synthesis of human osteoarthritis chondrocytes by targeting PIK3R1.

Authors:  Xu Cui; Shaojie Wang; Heguo Cai; Yuan Lin; Xinpeng Zheng; Bing Zhang; Chun Xia
Journal:  Sci Rep       Date:  2016-03-14       Impact factor: 4.379

10.  MicroRNA-33 suppresses CCL2 expression in chondrocytes.

Authors:  Meng Wei; Qingyun Xie; Jun Zhu; Tao Wang; Fan Zhang; Yue Cheng; Dongyang Guo; Ying Wang; Liweng Mo; Shuai Wang
Journal:  Biosci Rep       Date:  2016-05-06       Impact factor: 3.840

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.